|Product name||Recombinant SARS-CoV-2 S1+S2 ECD (S-ECD) Protein with His tag (Wild type, pre-fusion state plus post-fusion state)|
|Description||Recombinant SARS-CoV-2 S1+S2 ECD (S-ECD) Protein with His tag (Wild type, pre-fusion state plus post-fusion state) is produced by HEK293 cells expression system. The target protein is expressed with sequence (Val11-Gln1208) of SARS-COV-2(2019-nCoV) S1+S2 ECD (S-ECD) (Accession #YP_009724390.1) fused with a 6×His tag at the C-terminus.|
|Bio-Activity||Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Spike S1+S2 ECD-His at 2μg/mL (100 μL/well) can bind Recombinant Human ACE2 with a linear range of 0.15-9.92 ng/mL.|
|Purity||>97% by SDS-PAGE.|
|Endotoxin||< 0.1 EU/μg of the protein by LAL method.|
|Formulation||Supplied as a 0.22 μm filtered solution in PBS, pH 7.4.Contact us for customized product form or formulation.Contact us for customized product form or formulation.|
|Synonym||cov spike Protein; 2019-nCoV; ncov spike Protein; 2019-nCoV; coronavirus spike Protein; 2019-nCoV; S glycoprotein; COVID-19; S protein; Spike glycoprotein|
|Expressed Host||HEK293 cells|
|Storage||This product is stable at ≤ ‑70°C for up to 6 months from the date of receipt. |
For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.
* For research use only. Not for therapeutic or diagnostic purposes.
Submit your question about RP01260LQ below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.
Publishing research using RP01260LQ? Please let us know so that we can cite the reference in this datasheet.